Company Overview and News

 
Construction of new dam nears

2018-05-05 newsinfo.inquirer.net
Bids for the construction of the P13.4-billion Kaliwa Dam project in Quezon province are scheduled for submission on May 11 with the contract award and signing set in August this year.

 
China loans for PH firmed up

2018-03-08 business.inquirer.net
The Philippine and Chinese governments are set to sign by midyear the loan agreements for the three big-ticket infrastructure projects to be financed by the mainland.

 
Daya Materials hit by selldown

2018-03-04 thestar.com.my
KUALA LUMPUR: Daya Materials Bhd shares have taken a hit from a wide selldown to an all-time low of four sen, after the group triggered the Practice Note 17 (PN17) criteria last Thursday.

 
CEZA commissions study of infrastructure needs to attract fintech firms

2018-02-02 bworldonline
CAGAYAN Economic Zone Authority (CEZA) said it signed a memorandum of understanding with Sinosun Subic Bay Holdings Corp. to conduct a feasibility study for the development of a financial technology (fintech) hub.

 
Chinese construction firm holds due diligence on planned LNG project in PH

2017-11-24 business.inquirer.net
A subsidiary of Chinese construction giant China Energy Engineering Corp. Ltd. has started a yearlong due diligence that would lead to a decision on whether it would pursue a liquefied natural gas (LNG) project with MRC Allied Inc.

 
China lines up contractors for key water infra projects

2017-09-17 bworldonline
THE CHINESE GOVERNMENT has submitted a list of companies bidding for the New Centennial Water Source-Kaliwa Dam Project and the Chico River Pump Irrigation Project, the Department of Finance (DoF) said.

 
Sarawak Energy awards Baleh dam contract to Chinese joint venture

2017-06-29 themalaymailonline
The Baleh dam will generate an additional 1,285 MW of renewable energy to the grid when fully commissioned in 2025, SEB’s group chief executive officer Sharbini Suhaili said. ― Picture courtesy of YouTube/RTM newsKUCHING, June 29 — State-owned power provider Sarawak Energy Berhad (SEB) has awarded the main civil works contract to construct the Baleh dam to a joint venture between China Gezhouba Group Company Ltd (CGGC) and local firm Untang Jaya Sdn Bhd.

 
China Energy Engineering makes foray into power distribution

2017-01-17 scmp
China Energy Engineering, one of the nation’s biggest power plant designers and builders, is expanding into the newly opened up business of power distribution previously operated by state monopolies, according to its chief.

 
Ivory Coast 372 MW power plant financed by China build starts

2016-09-15 reuters
ABIDJAN, Sept 15 Building work has started in Ivory Coast on a 372-megawatt power plant worth 500 million euros financed mainly by China Construction Bank and set to open in 2018, Richard Amon, chairman of Star Energie 2073, said on Thursday.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...